Hot flushes, changing periods, disrupted sleep, low mood and brain fog can begin while your cycles are still happening. It is understandable to want a blood result that confirms perimenopause. The difficult part is that hormone levels can change sharply from one day or cycle to another, so one snapshot often cannot answer the question on its own.
A panel may measure follicle-stimulating hormone (FSH), luteinising hormone (LH), oestradiol, progesterone and testosterone. Together they describe parts of ovarian and pituitary signalling at the collection time. They can be useful in selected situations, but they do not grade how severe your symptoms are, predict exactly when your final period will occur or determine whether treatment is suitable.
For otherwise healthy people aged 45 or over with typical symptoms, NICE advises identifying perimenopause or menopause without laboratory tests. Blood tests become more relevant when symptoms occur earlier, periods are difficult to interpret, another condition is possible or a clinician needs to investigate a particular question.
What this test measures
FSH is released by the pituitary gland to stimulate ovarian follicles. As ovarian responsiveness changes, FSH can rise, but it may move back into a premenopausal range in another cycle. LH is another pituitary hormone involved in ovulation and can also vary considerably.
Oestradiol is the main circulating oestrogen during reproductive years. Levels rise and fall through the cycle and can swing during perimenopause. Progesterone rises after ovulation; a low value may simply reflect collection before ovulation, a cycle without ovulation or timing that missed its peak.
Testosterone is present in all sexes and contributes to sexual function, muscle and other tissues. A single level does not neatly explain libido, energy or mood. Hormonal contraception, hormone replacement therapy, pregnancy, medicines and time of collection can all alter the pattern across the panel.
When testing may be useful
A panel may add context if you are aged 40 to 45 with menopause-associated symptoms and a cycle change, or under 40 when premature ovarian insufficiency is being considered. Those situations need clinician involvement: NICE advises that premature ovarian insufficiency should not be identified from a single blood test.
Testing can also help when symptoms overlap with thyroid problems, pregnancy, high prolactin or another cause, although those questions may require additional markers. If you use hormonal contraception or HRT, tell the service exactly what and when you take it because results may be difficult or inappropriate to interpret without that information.
Seek direct medical advice for very heavy bleeding, bleeding after sex, bleeding after 12 months without a period, a new breast lump, severe pelvic pain or symptoms that are seriously affecting daily life. A hormone panel does not assess these concerns safely on its own.
What your results can mean
There is no universal “perimenopause number”. Higher FSH with lower oestradiol can fit reduced ovarian activity, but a different collection day can show another pattern. Results should be read against your age, cycle day, last menstrual period, symptoms and hormone use.
A progesterone result is especially timing-dependent. If the aim is to check whether ovulation occurred, collection is usually planned relative to the next expected period rather than always on a fixed calendar day. Irregular cycles make that harder and may require clinical planning.
A result within a premenopausal range does not exclude perimenopause. Equally, one raised FSH value does not prove that periods have permanently stopped. Treatment decisions are generally based on symptoms, preferences, risks and benefits rather than on reaching a target hormone value.
What to do next
Before testing, record your age, first day of the last few periods, typical cycle length, symptoms and every hormone-containing medicine. Follow any timing instruction supplied with the panel. If timing is not specified, ask the provider what clinical question the collection day is intended to answer.
Use the report to support a conversation with your GP, particularly if you are under 45, symptoms are difficult to manage or results are unexpected. Discuss contraception as well as symptom treatment: pregnancy can still occur during perimenopause.
Lifestyle support, non-hormonal options and HRT may all be considered depending on your needs and health history. The value of testing is to add context where context is needed—not to make you wait for laboratory confirmation before discussing disruptive symptoms.
See the Menopause/Perimenopause Panel, read what an AMH result says about ovarian reserve, or explore women's health tests.
References
- NICE: Menopause identification and management
- NHS: Menopause and perimenopause
- NHS: Periods and the menstrual cycle
Sources: NICE: Menopause identification and management; NHS: Menopause and perimenopause; NHS: Periods and the menstrual cycle — see all references